Pred-Mild (Prednisolone Acetate Ophthalmic) - Summary

PRED-MILD SUMMARY

PRED MILD^®
(prednisolone acetate ophthalmic suspension, USP) 0.12%

PRED MILD^® (prednisolone acetate ophthalmic suspension, USP) 0.12% is a topical anti-inflammatory agent for ophthalmic use.

PRED MILD^® is indicated for the treatment of mild to moderate noninfectious allergic and inflammatory disorders of the lid, conjunctiva, cornea, and sclera (including chemical and thermal burns).

See all Pred-Mild indications & dosage >>

PRED-MILD NEWS HIGHLIGHTS

Published Studies Related to Pred-Mild (Prednisolone Ophthalmic)

Efficacy of methylprednisolone injected into the masseter muscle following the surgical extraction of impacted lower third molars. [2008.03]

Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. [2008.02]

Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery. [2007.10]

High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.09]

Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. [2007.09]

more >>

Clinical Trials Related to Pred-Mild (Prednisolone Ophthalmic)

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge Model [Active, not recruiting]

Scandinavian Bell's Palsy Study [Completed]

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [Completed]

A Comparison of Three Different Formulations of Prednisolone Acetate 1% [Recruiting]

The Efficacy of Three Months-Prednisolone Therapy for Chronic Eosinophilic Pneumonia [Recruiting]

more >>